Profound Medical Corp. (PROF)Healthcare | Medical Devices | Mississauga, Canada | NasdaqCM
6.66 USD
+0.04
(0.529%)
⇧
(Oct. 15, 2026, 10:07 a.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 5:14 a.m. EDT
The investment case for Profound Medical is currently broken by a severe multi-year structural decline. While the company boasts a fortress balance sheet with a current ratio of 6.46 and manageable debt, the stock has lost nearly two-thirds of its value over the last five years, with the last two years showing consecutive declines. This trajectory overrides the positive news regarding trial data and reimbursement outlooks; the market has priced in a fundamental deterioration that hasn't yet been reversed. The absence of a dividend and negative free cash flow further erodes the value proposition for income investors. On the short end, the heavy put positioning and elevated implied volatility suggest traders are bracing for further weakness, making this a defensive hold at best rather than a momentum play. Until the price trajectory turns positive and the consecutive losses are halted, the long-term rating remains weak due to the persistent failure of the stock to recover its value despite the underlying medical device sector's potential. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.109728 |
| AutoTheta | 0.111139 |
| AutoARIMA | 0.111446 |
| AutoETS | 0.111744 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 8.26 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.583 |
| Excess Kurtosis | -0.74 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 14.817 |
| Revenue per Share | 0.572 |
| Market Cap | 243,124,400 |
| Forward P/E | -11.32 |
| Beta | 0.56 |
| Profit Margins | -171.56% |
| Website | https://www.profoundmedical.com |
As of Oct. 10, 2026, 5:14 a.m. EDT: Speculators are heavily positioned for downside protection, with significant open interest in out-of-the-money puts at the $5.00 strike compared to minimal call activity. Implied volatility is notably higher for puts (3.4x) than calls, indicating a market expectation of a sharp drop rather than a rally. The lack of call volume suggests a lack of conviction in an immediate upside move.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.19064748 |
| Address1 | 2,400 Skymark Avenue |
| Address2 | Unit 6 |
| All Time High | 28.97 |
| All Time Low | 3.1 |
| Ask | 8.46 |
| Ask Size | 2 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 525,050 |
| Average Daily Volume3 Month | 185,120 |
| Average Volume | 185,120 |
| Average Volume10Days | 525,050 |
| Beta | 0.555 |
| Bid | 5.01 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 1.363 |
| City | Mississauga |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 10 |
| Country | Canada |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.655 |
| Current Ratio | 6.459 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 6.7 |
| Day Low | 6.58 |
| Debt To Equity | 14.817 |
| Display Name | Profound Medical |
| Dividend Date | 1,571,184,000 |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,908,800 |
| Earnings Call Timestamp Start | 1,793,908,800 |
| Earnings Timestamp | 1,793,908,800 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -34,878,000 |
| Ebitda Margins | -1.82741 |
| Enterprise To Ebitda | -6.048 |
| Enterprise To Revenue | 11.053 |
| Enterprise Value | 210,954,768 |
| Eps Current Year | -0.8375 |
| Eps Forward | -0.588 |
| Eps Trailing Twelve Months | -0.94 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 647 847 3739 |
| Fifty Day Average | 6.5181 |
| Fifty Day Average Change | 0.13690042 |
| Fifty Day Average Change Percent | 0.02100312 |
| Fifty Two Week Change Percent | 19.064749 |
| Fifty Two Week High | 8.95 |
| Fifty Two Week High Change | -2.2949996 |
| Fifty Two Week High Change Percent | -0.25642455 |
| Fifty Two Week Low | 4.8 |
| Fifty Two Week Low Change | 1.855 |
| Fifty Two Week Low Change Percent | 0.3864583 |
| Fifty Two Week Range | 4.8 - 8.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,572,355,800,000 |
| Float Shares | 35,503,106 |
| Forward Eps | -0.588 |
| Forward P E | -11.3180275 |
| Free Cashflow | -24,819,624 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 162 |
| Fullday Change | 0.035000324 |
| Fullday Change Percent | 0.52870584 |
| Fullday Price | 6.655 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.71786004 |
| Gross Profits | 13,701,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04088 |
| Held Percent Institutions | 0.45026 |
| Implied Shares Outstanding | 36,532,594 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. |
| Long Name | Profound Medical Corp. |
| Market | us_market |
| Market Cap | 243,124,400 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_108191898 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -32,744,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 210,640,779 |
| Number Of Analyst Opinions | 5 |
| Open | 6.58 |
| Operating Cashflow | -36,101,000 |
| Operating Margins | -4.45671 |
| Overall Risk | 10 |
| Phone | 647 476 1350 |
| Previous Close | 6.62 |
| Price Eps Current Year | -7.946269 |
| Price Hint | 2 |
| Price To Book | 4.8826118 |
| Price To Sales Trailing12 Months | 12.738363 |
| Profit Margins | -1.7156 |
| Quick Ratio | 5.255 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.035000324 |
| Regular Market Change Percent | 0.52870584 |
| Regular Market Day High | 6.7 |
| Regular Market Day Low | 6.58 |
| Regular Market Day Range | 6.58 - 6.7 |
| Regular Market Open | 6.58 |
| Regular Market Previous Close | 6.62 |
| Regular Market Price | 6.655 |
| Regular Market Time | 1,792,073,235 |
| Regular Market Volume | 12,539 |
| Return On Assets | -0.39456 |
| Return On Equity | -0.73527 |
| Revenue Growth | 0.123 |
| Revenue Per Share | 0.572 |
| Sand P52 Week Change | 0.16440773 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 36,532,594 |
| Shares Percent Shares Out | 0.040599998 |
| Shares Short | 1,483,293 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,619,987 |
| Short Name | Profound Medical Corp. |
| Short Percent Of Float | 0.045900002 |
| Short Ratio | 11.8 |
| Source Interval | 15 |
| State | ON |
| Symbol | PROF |
| Target High Price | 12.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 11.14 |
| Target Median Price | 11.2 |
| Total Cash | 38,271,000 |
| Total Cash Per Share | 1.048 |
| Total Debt | 7,380,000 |
| Total Revenue | 19,086,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.94 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.7981 |
| Two Hundred Day Average Change | -0.14309978 |
| Two Hundred Day Average Change Percent | -0.021049967 |
| Type Disp | Equity |
| Volume | 12,539 |
| Website | https://www.profoundmedical.com |
| Zip | L4W 5K5 |